Pharma Journalist - Page 26 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Antengene Licenses ATG-201 to UCB in $1.1B Deal

Esperion to Acquire Corstasis, Expanding Heart Failure Treatment Portfolio

Japan Grants Orphan Drug Status to Rilzabrutinib for IgG4 Disease

Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing

Sinopia and Ono Partner to Discover Targets for Rare Metabolic Diseases

Quotient Sciences Extends Ipsen FOP Supply Deal

Japan Reviews GSK’s Bepirovirsen for Hepatitis B

China Grants Priority Review to GSK’s Linerixibat

Novo Nordisk Partners Vivtex on Oral Biologics

IQVIA to Acquire Discovery Assets from Charles River